All Stories

  1. Shaping the Future of HTA in Italy: Insights from the Italian Health Policy Forum
  2. Health technology assessment (HTA) of prostatic urethral lift (PUL) for the treatment of benign prostatic hyperplasia (BPH) in the Italian context
  3. Towards a Green Health Technology Assessment: embedding Life Cycle Assessment for sustainable choices
  4. Functional coronary assessment in angina with intermediate coronary stenosis: the #FullPhysiology approach
  5. Policy predictive model for better management of chronic obstructive pulmonary disease: economic-organisational implications in the Italian healthcare system
  6. Cost effectiveness of difelikefalin for the treatment of patients with chronic kidney disease-associated pruritus undergoing hemodialysis in Italy
  7. The economic and social burden of congenital thrombotic thrombocytopenic purpura (cTTP) in Italy
  8. The socio-environmental determinants of diabetes and their consequences
  9. Price and reimbursement of medicines when new indications are approved: the results of a survey on ISPOR Italy Rome Chapter members
  10. Feasibility of a Stop Smoking Program for Healthcare Workers in an Italian Hospital: Econometric Analysis in a Total Worker Health® Approach
  11. The added value of applying a disinvestment approach to the process of health technology assessment in Italy
  12. Estimated direct costs of non‐small cell lung cancer by stage at diagnosis and disease management phase: A whole‐disease model
  13. Return on Investment (ROI) and Development of a Workplace Disability Management Program in a Hospital—A Pilot Evaluation Study
  14. A cost-minimization analysis of a preventive testing strategy for relatives of patients with BRCA mutated ovarian cancer
  15. Estimating the fiscal impact of three vaccination strategies in Italy
  16. NutriCatt protocol in the Enhanced Recovery After Surgery (ERAS) program for colorectal surgery: The nutritional support improves clinical and cost-effectiveness outcomes
  17. PD43 Value-Based Procedure For Updating The Italian Health Benefit Package
  18. Evolution of the Healthcare Expenditure in Italy and Effects of Fingolimod Increased Prescribing in Second Line Treatment of Relapsing-Remitting Multiple Sclerosis
  19. Economic evaluation of screening programs for hepatitis C virus infection: evidence from literature